Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts

Background: Metastatic breast cancer (MBC) is currently an incurable condition that is primarily treated with palliative measures. Isolation of circulating tumor cells (CTCs) from the peripheral blood of these patients provides a predictive prognostic indicator, independent of the type of therapy, s...

Full description

Bibliographic Details
Published in:Annals of Oncology
Main Author: Saldova R.; Reuben J.M.; Abd Hamid U.M.; Rudd P.M.; Cristofanilli M.
Format: Article
Language:English
Published: Oxford University Press 2011
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-79551481037&doi=10.1093%2fannonc%2fmdq570&partnerID=40&md5=8579917153898a944bc3cf46b5dda0ff